These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27287481)

  • 1. Spinal multiparametric MRI and DEXA changes over time in men with prostate cancer treated with androgen deprivation therapy: a potential imaging biomarker of treatment toxicity.
    Martin J; Arm J; Smart J; Palazzi K; Capp A; Ainsworth P; Cowin G
    Eur Radiol; 2017 Mar; 27(3):995-1003. PubMed ID: 27287481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
    Bergamini M; Dalla Volta A; Palumbo C; Zamboni S; Triggiani L; Zamparini M; Laganà M; Rinaudo L; Di Meo N; Caramella I; Bresciani R; Valcamonico F; Borghetti P; Guerini A; Farina D; Antonelli A; Simeone C; Mazziotti G; Berruti A
    Elife; 2024 Apr; 13():. PubMed ID: 38656229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation of vertebral marrow adipose tissue in postmenopausal female using MRI chemical shift-based water-fat separation.
    Li GW; Xu Z; Chen QW; Tian YN; Wang XY; Zhou L; Chang SX
    Clin Radiol; 2014 Mar; 69(3):254-62. PubMed ID: 24286935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition.
    Taaffe DR; Galvão DA; Spry N; Joseph D; Chambers SK; Gardiner RA; Hayne D; Cormie P; Shum DHK; Newton RU
    BJU Int; 2019 Feb; 123(2):261-269. PubMed ID: 30239116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen deprivation therapy for prostate cancer results in significant loss of bone density.
    Wei JT; Gross M; Jaffe CA; Gravlin K; Lahaie M; Faerber GJ; Cooney KA
    Urology; 1999 Oct; 54(4):607-11. PubMed ID: 10510915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive decrease in bone density over 10 years of androgen deprivation therapy in patients with prostate cancer.
    Kiratli BJ; Srinivas S; Perkash I; Terris MK
    Urology; 2001 Jan; 57(1):127-32. PubMed ID: 11164157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vertebral fractures and trabecular microstructure in men with prostate cancer on androgen deprivation therapy.
    Greenspan SL; Wagner J; Nelson JB; Perera S; Britton C; Resnick NM
    J Bone Miner Res; 2013 Feb; 28(2):325-32. PubMed ID: 22991066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.
    Greenspan SL; Coates P; Sereika SM; Nelson JB; Trump DL; Resnick NM
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6410-7. PubMed ID: 16189261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values.
    Wadhwa VK; Weston R; Mistry R; Parr NJ
    BJU Int; 2009 Sep; 104(6):800-5. PubMed ID: 19338564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percentage fat fraction in magnetic resonance imaging: upgrading the osteoporosis-detecting parameter.
    Chang R; Ma X; Jiang Y; Huang D; Chen X; Zhang M; Hao D
    BMC Med Imaging; 2020 Mar; 20(1):30. PubMed ID: 32183731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of androgen deprivation therapy on bone mineral density in men with prostate cancer].
    Deng J; Li W; Yang L; Wang L; Zou D
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):761-3. PubMed ID: 15562791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy.
    Berruti A; Dogliotti L; Terrone C; Cerutti S; Isaia G; Tarabuzzi R; Reimondo G; Mari M; Ardissone P; De Luca S; Fasolis G; Fontana D; Rossetti SR; Angeli A;
    J Urol; 2002 Jun; 167(6):2361-7; discussion 2367. PubMed ID: 11992038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and predictors of fatigue in men with prostate cancer receiving radiotherapy and androgen deprivation therapy.
    Bandara V; Capp A; Ahmed G; Arm J; Martin J
    J Med Imaging Radiat Oncol; 2019 Oct; 63(5):683-690. PubMed ID: 31588674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing bone loss during androgen deprivation therapy for prostate cancer: early experience with neridronate.
    Magno C; Anastasi G; Morabito N; Gaudio A; Maisano D; Franchina F; Galì A; Frisina N; Melloni D
    Eur Urol; 2005 May; 47(5):575-80; discussion 580-1. PubMed ID: 15826746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
    Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
    Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertebral bone marrow fat content in normal adults with varying bone densities at 3T magnetic resonance imaging.
    He J; Fang H; Li X
    Acta Radiol; 2019 Apr; 60(4):509-515. PubMed ID: 30130978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density, pathological fractures and bisphosphonate therapy in prostate cancer patients on androgen deprivation therapy.
    Ziaran S; Goncalves FM; Breza JS
    Endocr Regul; 2011 Oct; 45(4):199-204. PubMed ID: 22073949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous Estimation of the Fat Fraction and R₂
    Kim D; Kim SK; Lee SJ; Choo HJ; Park JW; Kim KY
    Korean J Radiol; 2019 Jun; 20(6):916-930. PubMed ID: 31132817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid determination of vertebral fat fraction over a large range of vertebral bodies.
    Martin J; Nicholson G; Cowin G; Ilente C; Wong W; Kennedy D
    J Med Imaging Radiat Oncol; 2014 Apr; 58(2):155-63. PubMed ID: 24373427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.